- Meets the Influenza reclassification requirements for rapid antigen tests* Influenza A Sensitivity: 90.3% Specificity: 96.7% Influenza B Sensitivity: 88% Specificity: 99.2%
- Influenza A Sensitivity: 90.3% Specificity: 96.7%
- Sensitivity: 90.3%
- Specificity: 96.7%
- Influenza B Sensitivity: 88% Specificity: 99.2%
- Sensitivity: 88%
- Specificity: 99.2%
- Time to results in 15-20 mins
- Collection Method: Anterior Nasal
- For use under an Emergency Use Authorization (EUA) Only
- For in vitro diagnostic use only
- For professional use only
- Letter of Authorization
GenBody and OSOM COVID-19/FLU A/B Rapid Test Promo Package
$362.00
- SKU:
- clia_waived-COVIDFLU-GenBody-Package